TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

re: Ann: VitroGro ECM CE Mark Approval Referr... My frustration...

  1. advisor71
    878 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    08/08/12
    09:35
    Post #: 10540599
    re: Ann: VitroGro ECM CE Mark Approval Referr... My frustration is over just who is handling the CE process and how much they are getting paid by TIS. One would think that someone would have known all the hurdles that needed to be jumped before final CE approval is given. From the News Release it appeared to me that the company was in the dark as they expected CE approval. Now more processes to be followed. Not a very good look for TIS with these sorts of delays.

    I still hold a good volume of stock and should we drop back in price then will be in for a bit more.

    Good luck to all long term holders.
    TIS Price at posting: 45.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.